BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30991092)

  • 1. Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: An UNGAP review.
    Vertzoni M; Augustijns P; Grimm M; Koziolek M; Lemmens G; Parrott N; Pentafragka C; Reppas C; Rubbens J; Van Den Αbeele J; Vanuytsel T; Weitschies W; Wilson CG
    Eur J Pharm Sci; 2019 Jun; 134():153-175. PubMed ID: 30991092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of advanced methods and models to study drug absorption and related processes: An UNGAP perspective.
    Wilson CG; Aarons L; Augustijns P; Brouwers J; Darwich AS; De Waal T; Garbacz G; Hansmann S; Hoc D; Ivanova A; Koziolek M; Reppas C; Schick P; Vertzoni M; García-Horsman JA
    Eur J Pharm Sci; 2022 May; 172():106100. PubMed ID: 34936937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network.
    Vinarov Z; Abrahamsson B; Artursson P; Batchelor H; Berben P; Bernkop-Schnürch A; Butler J; Ceulemans J; Davies N; Dupont D; Flaten GE; Fotaki N; Griffin BT; Jannin V; Keemink J; Kesisoglou F; Koziolek M; Kuentz M; Mackie A; Meléndez-Martínez AJ; McAllister M; Müllertz A; O'Driscoll CM; Parrott N; Paszkowska J; Pavek P; Porter CJH; Reppas C; Stillhart C; Sugano K; Toader E; Valentová K; Vertzoni M; De Wildt SN; Wilson CG; Augustijns P
    Adv Drug Deliv Rev; 2021 Apr; 171():289-331. PubMed ID: 33610694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of gastrointestinal physiology on drug absorption in special populations--An UNGAP review.
    Stillhart C; Vučićević K; Augustijns P; Basit AW; Batchelor H; Flanagan TR; Gesquiere I; Greupink R; Keszthelyi D; Koskinen M; Madla CM; Matthys C; Miljuš G; Mooij MG; Parrott N; Ungell AL; de Wildt SN; Orlu M; Klein S; Müllertz A
    Eur J Pharm Sci; 2020 Apr; 147():105280. PubMed ID: 32109493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo Predictive Dissolution (IPD) and Biopharmaceutical Modeling and Simulation: Future Use of Modern Approaches and Methodologies in a Regulatory Context.
    Lennernäs H; Lindahl A; Van Peer A; Ollier C; Flanagan T; Lionberger R; Nordmark A; Yamashita S; Yu L; Amidon GL; Fischer V; Sjögren E; Zane P; McAllister M; Abrahamsson B
    Mol Pharm; 2017 Apr; 14(4):1307-1314. PubMed ID: 28195732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologically Based In vitro Models to Predict the Oral Dissolution and Absorption of a Solid Drug Delivery System.
    Li Z; He X
    Curr Drug Metab; 2015; 16(9):777-806. PubMed ID: 26264200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Navigating the human gastrointestinal tract for oral drug delivery: Uncharted waters and new frontiers.
    Koziolek M; Grimm M; Schneider F; Jedamzik P; Sager M; Kühn JP; Siegmund W; Weitschies W
    Adv Drug Deliv Rev; 2016 Jun; 101():75-88. PubMed ID: 27037063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanisms of pharmacokinetic food-drug interactions - A perspective from the UNGAP group.
    Koziolek M; Alcaro S; Augustijns P; Basit AW; Grimm M; Hens B; Hoad CL; Jedamzik P; Madla CM; Maliepaard M; Marciani L; Maruca A; Parrott N; Pávek P; Porter CJH; Reppas C; van Riet-Nales D; Rubbens J; Statelova M; Trevaskis NL; Valentová K; Vertzoni M; Čepo DV; Corsetti M
    Eur J Pharm Sci; 2019 Jun; 134():31-59. PubMed ID: 30974173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolving intraluminal drug and formulation behavior: Gastrointestinal concentration profiling in humans.
    Brouwers J; Augustijns P
    Eur J Pharm Sci; 2014 Sep; 61():2-10. PubMed ID: 24495579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects.
    Sjögren E; Abrahamsson B; Augustijns P; Becker D; Bolger MB; Brewster M; Brouwers J; Flanagan T; Harwood M; Heinen C; Holm R; Juretschke HP; Kubbinga M; Lindahl A; Lukacova V; Münster U; Neuhoff S; Nguyen MA; Peer Av; Reppas C; Hodjegan AR; Tannergren C; Weitschies W; Wilson C; Zane P; Lennernäs H; Langguth P
    Eur J Pharm Sci; 2014 Jun; 57():99-151. PubMed ID: 24637348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of paediatric gastrointestinal physiology relevant to the absorption of orally administered medicines.
    Wollmer E; Ungell AL; Nicolas JM; Klein S
    Adv Drug Deliv Rev; 2022 Feb; 181():114084. PubMed ID: 34929252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review.
    Vinarov Z; Abdallah M; Agundez JAG; Allegaert K; Basit AW; Braeckmans M; Ceulemans J; Corsetti M; Griffin BT; Grimm M; Keszthelyi D; Koziolek M; Madla CM; Matthys C; McCoubrey LE; Mitra A; Reppas C; Stappaerts J; Steenackers N; Trevaskis NL; Vanuytsel T; Vertzoni M; Weitschies W; Wilson C; Augustijns P
    Eur J Pharm Sci; 2021 Jul; 162():105812. PubMed ID: 33753215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo.
    Lennernäs H; Aarons L; Augustijns P; Beato S; Bolger M; Box K; Brewster M; Butler J; Dressman J; Holm R; Julia Frank K; Kendall R; Langguth P; Sydor J; Lindahl A; McAllister M; Muenster U; Müllertz A; Ojala K; Pepin X; Reppas C; Rostami-Hodjegan A; Verwei M; Weitschies W; Wilson C; Karlsson C; Abrahamsson B
    Eur J Pharm Sci; 2014 Jun; 57():292-9. PubMed ID: 24189462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
    Berlin M; Przyklenk KH; Richtberg A; Baumann W; Dressman JB
    Eur J Pharm Biopharm; 2014 Nov; 88(3):795-806. PubMed ID: 25195981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Best practices in current models mimicking drug permeability in the gastrointestinal tract - An UNGAP review.
    O'Shea JP; Augustijns P; Brandl M; Brayden DJ; Brouwers J; Griffin BT; Holm R; Jacobsen AC; Lennernäs H; Vinarov Z; O'Driscoll CM
    Eur J Pharm Sci; 2022 Mar; 170():106098. PubMed ID: 34954051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and optimized selection of supersaturating drug delivery systems of posaconazole (BCS class 2b) in the gastrointestinal simulator (GIS): An in vitro-in silico-in vivo approach.
    Hens B; Bermejo M; Tsume Y; Gonzalez-Alvarez I; Ruan H; Matsui K; Amidon GE; Cavanagh KL; Kuminek G; Benninghoff G; Fan J; Rodríguez-Hornedo N; Amidon GL
    Eur J Pharm Sci; 2018 Mar; 115():258-269. PubMed ID: 29378253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Abrahamsson B; Brewster M; Brouwers J; Butler J; Carlert S; Dickinson PA; Dressman J; Holm R; Klein S; Mann J; McAllister M; Minekus M; Muenster U; Müllertz A; Verwei M; Vertzoni M; Weitschies W; Augustijns P
    Eur J Pharm Sci; 2014 Jun; 57():342-66. PubMed ID: 23988843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro models for the prediction of in vivo performance of oral dosage forms: Recent progress from partnership through the IMI OrBiTo collaboration.
    Butler J; Hens B; Vertzoni M; Brouwers J; Berben P; Dressman J; Andreas CJ; Schaefer KJ; Mann J; McAllister M; Jamei M; Kostewicz E; Kesisoglou F; Langguth P; Minekus M; Müllertz A; Schilderink R; Koziolek M; Jedamzik P; Weitschies W; Reppas C; Augustijns P
    Eur J Pharm Biopharm; 2019 Mar; 136():70-83. PubMed ID: 30579851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.